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INTRAHEPATIC OBSTRUCTIVE JAUNDICE
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OBs-mucTivF jaundice is amenable to surgical treatment when the obstruction is
extrahepatic. In recent years it has been recognised that the obstruction may be
intrahepatic and the complete picture of obstructive jaundice may be seen without
obstruction of the main bile ducts. It is important to differentiate between
intrahepatic anid extrahepatic cholestasis in order to avoid unnecessary surgical
interference. In differential diagnosis liver function tests are valuable. Liver
biopsy, which can be conveniently done with a Menghini liver biopsy needle,
may be diagnostic.
In view of the diagnostic difficultv a report of a case of intrahepatic cholestasis
might be of interest. The significance of liver function tests and the multiple
atiology of intrahepatic cholestasis are discussed.
CASE REPORT.
The patient was a woman aged 71 years. She was admitted to hospital on
29th March, 1962. She gave a history of painless jaundice of six weeks' duration,
and she had troublesome pruritus. She had noticed the urine to be dark and
the stools pale. There was no history of recent drug administration. Apart from
severe icterus, clinical examination was not remarkable. The liver was not
enlarged, and the gall bladder not palpable. The urine contained bile salts and
bile pigment. Urobilinogen was not detected.
Liver function tests:
Bilirubin
Total - - - - 25.6 mgm.01
Direct - - - - 16.9 mgm.03
Alkaline Phosphatase - - - 4 units
Transaminase (SGOT) - - - 20 units
Cholesterol - - - - 215 mgm.0,,
Plasma Proteins
Albumin - - - - 3.7 G. per 100 ml.
Alpha 1 Globulin - - .20 G.
Alpha 2 Globulin - - .50 G.
Beta Globulin - - - .60 G.
Gamma Globulin - - .90 G.
LIVER Biopsy. "It cannot be appreciated that there is any distortion of the
lobular architecture. There is a very considerable inspissation of bile pigment
within the intralobular bile canaliculi and this appears to be most marked in
relation to the more central portions of the lobule. There is just a little variation
in an occasional liver cell nucleus and in the one or two tiny portal triads is
26a slight increased cellularity. Bile ducts cannot be detected. Subacute hepatitis
with intralobular inspissation of bile."
Laparotomy was advised to exclude extrahepatic obstruction. There was no
evidence of obstruction of the common bile duct. The liver and gall bladder
appeared normal. She madc a complete clinical and biochemical recovery
during the two nmonths subsequenit to operation.
LIVER FUNCTION TESTS.
A persistent bilirubinlnmia of 1.5 mg. per cent. or higher niust be present
before noticeable discoloration takes place. Bilirubin is a derivative of the iron-free
porphyrin fraction of hxmoglobin and is formed in the reticulo-endothelial
system where breakdown of erythrocytes takes place; approximately 300 mg. of
bilirubin is fornmed daily. When liberated into the blood stream from the sites
of formation, bilirubin gives an indirect van den Bergh with diazotized sulphanilic
acid. It is insoluble in water and is not excreted by the kidney. Indirect-reacting
bilirubin is readily taken up by hepatic cells via the sinusoids which receive blood
from both the portal vein and the hepatic artery. Bilirubin is conjugated with
glucoronic acid in the microsomes of the liver cells as a result of enzyme action
of glucoronyl transferase. Conjugated bilirubin is water-soluble and gives a direct
van den Bergh reaction.
In the intestine bilirubin undcrgocs reduction by bacterial action. The main
product is urobilinogen which is partially re-oxidised to urobilin. Sim1all am0ouIts
of urobilin and urobilinogen are re-absorbed from the intestine and most of this
is re-excreted by the liver after re-oxidation to bilirubin. The very small amount
of absorbed urobilinogen not re-excreted by the norimial liver passes into the
systemic blood stream and is excreted in the urinc. This amount does not give the
usual qualitative test for urobilinogen.
Hyperbilirubininiia can be produced in three ways: -
(1) By obstruction to the outflow of bile; the pigment in the plasma is chiefly
conjugated bilirubin.
(2) By excessive production of bilirubin-as in hxmolytic jaunidice; the pigment
in the plasma is chiefly free bilirubin. The normal liver has a great capacitxy
to conjugate bilirubin, the amount excreted increasing in proportion to the
square of the concentration in the plasma.
(3) By inability of damaged liver cells to transmit even the normal amounts
of bilirubin as in the clinical "toxic" and "infective" types of jaundice.
Hepatogenous jaundice is usually associated with some degree of obstruction
to the bile flow and both frec and conjugated bilirubin appear in the
plasma.
The van den Bergh measures the concentration of bilirubin in the plasma.
Normally the concentrationi is between 0.1 and 0.8 mg. per 100 ml. of serum.
The van den Bergh is of doubtful value in differential diagniosis of jaundice, but
it is useful as a quantitative measure and is valuable in assessing progress of the
case.
Bilirubinuria occurs when serum conjugated bilirubin exceeds 2 mg. per 100 ml.
Urobilinogen occurs in the urine in conditions associated with excessive pro-
27duction and excretion of bilirubin. One of the most difficult functions of the
hepatic cells is the re-oxidation of urobilinogen to bilirubin. One of the earliest
signs of hepatic cellular damage is excessive excretion of urobilinogen in the urine.
Urobilinogen may be detected in the urine in cases of infective hepatitis before
the development of overt jaundice.
Serum alkaline phosphatase levels usually parallel the obstructive factor of
jaundice. The King and Armstrong method measures the liberation of phenol
from phenyl phosphate with fifteen minutes' incubation at 370 C. and with the
pH adjusted to 10.0. A plasma alkaline phosphatase greater than 35 K.A. units
per 100 ml. strongly suggests obstructive jaundice; a figure belowv 25 units per
100 ml. suggests hepatogenous jaundice. A clear differentiation is not always
possible because many cases give intermediate values.
The cholesterol of the plasma is usually increased above the normal of 240 mg.
per 100 ml. in cases of obstructive jaundice.
Many tests not based directly on the production and excretion of bile
constituents are of value in differential diagnosis of jaundice. In hepatogenous
jaundice tests based oni the metabolic functions show a greater abnormality than
those based on excretory funlctions. In obstructive jaundice the excretory
functions are more inmpaired.
Electrophoretic estiimiationl of the plasma proteins is one of the most valuable
of the nmetabolic liver funictioni tests. The liver is an important organ in the
synthesis of plasma proteins. Ilflammnatory and degenerative lesions of the liver
are manifested by chaniges in the plasma proteins, viz., a decrease in the albumin
anid an increase in the gammna globulin. Failure of synthesis accounts for the
hypoalbuminxnmia. The cause of the inicreased gamma globulin is obscure. In
obstructive jaundice there may be a rise in the beta globulin which reflects the
raised plasma cholesterol.
Changes in the plasnma proteins are the basis of the flocculation tests. The
behaviour of a colloidal solutioni of several proteins towards precipitating agents
depends upon the relative concentrations of the different proteins. The cephalin
cholesterol and thymol turbidity reflect changes in the plasma proteins. The
flocculation tests are normal in obstructive jaundice and are usually positive in
hepatogenous jaundice.
Estimation of certain enlzymes are of value in differential diagnosis. Serum
transaminases can be assayed by their activity in transferring an amino group
from glutamic acid to oxalacetic acid (SGOT) and from glutamic acid to pyruvic
acid (SGPT). The transaminases are elevated in hepatogenous jaundice with
parenchymal injury. Lactic dehydrogenase, wvhich catalyses the oxidation of
lactic acid to pyruvic acid, is also increased in cases of jaundice with hepato-
cellular damage.
Liver function tests Imiust be interpreted in relationship to the clinical findings.
An accurate diagnosis can be established in approximately 90 per cent. of cases.
Liver biopsy may be diagnostic in doubtful cases. It is important that the clinician
should appreciate the difficulty which confronts the pathologist in his interpre-
28tation of the hepatic changes in sections of liver biopsy. The main difficulty arises
in the distinction between intrahepatic and extrahepatic cholestasis. In extrahepatic
cholestasis there may be multiplication of bile ductules in the portal zones which
show a predominantly polymorph infiltration reflecting the cholangitis. In intra-
hepatic cholestasis there is inspissation of bile pigment within the intralobular bile
canaliculi ancd the bile ductules are flattened and inconspicuolls. In intrahepatic
cholestasis duie to drugs the portal zones may show an eosinophilic infiltrationi.
A block of the bile duct mav be shown by the technique of percutaneous
transhepatic cholangiography. In patients with extrahepatic cholestasis a bile duct
mnay, be punctured. The procedure carries a risk of biliary peritonitis and is not
recommended.
INTRAHF,PATTC CHOLESTASTS.
The mechanism of jaundice in intrahepatic cholestasis is doubtful. Electron
microscopy has showin distortion of the microvilli lining the bile canaliculi. An
additional factor may be a disturbance of intracellular bilirubin transport from
the hepatic cell into the bile canaliculus. As a consequence, bile accumulates in
the intralobular bile canaliculi. Obstruction of the bile ductules bv infiltrates
in the portal zones is unlikely to be a factor.
One important cause of intrahepatic cholestasis is the hepatotoxicity of drugs.
Certain drugs, including choloroform, carbon tetrachloride, tetrachlorethylene,
ethyl chloride, benzene derivatives, certain metallic poisons, iproniazid and other
hydrazine monoamine-oxidase inhibitors, isonicotinic acid, and pyrazinamide are
direct hepato-cellular poisons which produce centrizonal liver necrosis. This state
is reflected by high serum transaminase levels and abnormal plasma protein
pattern. Hepatic damage is often associated with acute renal tubular necrosis.
In contrast to this severe hepatocellular jaundice due to drugs is the more
benignl intrahepatic drug cholestasis which is manifested by painless, afebrile,
obstructive jaundice. The liver is not enlarged andc not tender. Liver biopsv may
be equivocal and such cases may come to laparotomy wvhich reveals the main
bile ducts to be patent.
There are two types of cholestatic drug jaundice. The first type is caused by
a hypersensitivity reaction and may follow administration of chlorpromazine
("largactil") and other phenothiazine derivatives such as promazine ("sparine")
aind trifluperazine ("stelazine"), para-aminosalicyclic acid, thiouracil, chlorpropa-
mide ("diabinese"), and nitrofurantoin ("furadantin"). Cholestatic jaundice
develops in about I per cent. of patients taking chlorpromazine. Jaundice may
follow a single dose or one day's treatment. The initial manifestations may be
leucopenia, eosinophilia, drug fever, and drug rash. Recovery usuallv takes place
within one to four weeks after the drug has been discontinued. Occasionally
jaundice is much more prolonged and the clinical picture in such cases simulates
primary biliarv cirrhosis. The serum cholesterol and alkaline phosphatase levels
are high from the outset.
The second type of acute intrahepatic drug cholestasis may complicate
treatment with methvltestosterone and other related steroids, including nore-
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Ithandrolone ("nilevar") and methandienone ("dianobol"). This type is not due
to hypersensitivity but is a straightforward consequence of dosage and duration
of administration. The clinical picture of steroidal jaundice resembles that seen in
chlorpromazine jaundice. Liver biopsy reveals inspissation of bile in the canaliculi
but there is no portal-zone cellular reaction as occurs with chlorpromazine
jaundice.
Another cause of intrahepatic obstructive jaundice is virus hepatitis. Jaundice
persists for several months and recovery is complete. This is in contrast to
subacute hepatitis and cirrhosis which may complicate an attack of virus hepatitis
and is conditioned bv methionine deficiency. The atypical hepatitis with intra-
hepatic cholestasis is the variety which has been called cholangiolitic hepatitis.
According to Dubin the xtiological agent is a variant of the virus of infective
hepatitis. In cholangiolitic hepatitis there is no biochemical evidence of
hepatocellular damage. The serum transaminase and the plasma protein pattern
are normal; the serum alkaline phosphatase is usually slightly raised. The patient,
in whom intrahepatic cholestasis is due to cholangiolitic hepatitis, sometimes
shows a dramatic response to corticosteroid therapy. Prednisolone, 40 mg. daily
for four days, may cause a fall in the serum bilirubin level. The action of
cortiscosteroid in alleviating the jaundice is obscure.
A rare type of intrahepatic cholestasis occurs during pregnancy.
Primarv biliarv cirrhosis is another type of intrahepatic cholestasis of obscure
mechanism. The onset is insidious anid liver biopsy shows mlarked infiltratioll in
the portal zones. SUMMARY.
The difficulty in diagnosis of intrahepatic obstructive jaundice may lead to
unnecessary surgical intervention because an incorrect diagnosis of extrahepatic
obtruction is made.
It is essential to elicit anv history of recent drug administration.
Fever, rigors, and leucocytosis indicate extrahepatic obstruction and reflect
secondarv infection in the dilated ducts.
Liver biopsy mav be diagnostic but it is sometimes difficult to distiniguisl
between intrahepatic and extrahepatic cholestasis.
Response to a trial of corticosteroid therapy would indicate intrahepatic
obstruction.
In doubtful cases serial liver function tests should be performed at weekly
intervals during a period of three to four weeks' observation.
Sonie patients may require laparotomv to establish a definitive diagnosis.
We are indebted to Dr. J. E. Morison for his report on the liver biopsy and to Dr. R. A.
Ncely for help and co-operation with the biochemical investigations.
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